Can’t we agree that there are some processes that MATTER and make really good targets for quality measures? Why is that so freaking hard?
I’ve been getting requests for the chapter on Ethical Issues in Hyperbaric medicine. Here’s how to get a copy.
The APWCA annual meeting is THE place to get the most up to date information on healthcare reform and public policy affecting wound care and hyperbaric medicine.
It’s a waste of my time to even TRY to use a cellular product on a patient with Medicare Advantage.
CMS doesn’t care enough about patient reported outcomes like Quality of Life to incentivize collecting it as a quality measure, and manufacturers don’t care enough to fund the additional analysis that is needed.
With the gutting of the bonus payments originally possible in MIPS, the small upwards fee adjustments available under MIPS can’t adjust for this, and the cost of complying with the Quality Payment Program (QPP) is exacerbating the problem.
Because if you become subject to MIPS the following year, you can get extra points for having improved in a category where your performance was not so great.